Moreover, VEGFA therapy may be beneficial in slowing the progression of Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), where vascular weakness further exacerbates the disease through further neuronal death [8]. The gene discussed is VEGFA; the disease is early-onset autosomal dominant Alzheimer disease.